Fintel reports that on January 23, 2025, Maxim Group upgraded their outlook for NAYA Biosciences (NasdaqCM:NAYA) from Hold to Buy.
What are Other Shareholders Doing?
CWC Advisors, LLC. holds 100K shares representing 1.42% ownership of the company.
VEXMX - Vanguard Extended Market Index Fund Investor Shares holds 54K shares representing 0.76% ownership of the company. No change in the last quarter.
Citadel Advisors holds 53K shares representing 0.74% ownership of the company. In its prior filing, the firm reported owning 0K shares , representing an increase of 100.00%.
Geode Capital Management holds 35K shares representing 0.50% ownership of the company. In its prior filing, the firm reported owning 33K shares , representing an increase of 7.35%. The firm decreased its portfolio allocation in NAYA by 17.85% over the last quarter.
FSMAX - Fidelity Extended Market Index Fund holds 20K shares representing 0.28% ownership of the company. In its prior filing, the firm reported owning 12K shares , representing an increase of 38.14%. The firm increased its portfolio allocation in NAYA by 36.78% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
